Cannabis Weekly Round-Up: Peru on Path for Legal Medical Cannabis
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Your trusted source for investing success
Your trusted source for investing success
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Shelly Kumar
High Hampton Holdings Corp. (CSE:HC) (“High Hampton” or the “Company“) is pleased to provide an update on its California operations. The Company has engaged Infrastructure Engineers, a multi-disciplinary municipal engineering firm located in Brea, California, to assemble and assist with the filing and processing of a conditional use permit (CUP) application for the Company’s 100%
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Here, the Investing News Network looks at publicly traded medical device and technology companies listed on the TSX.
Depomed a specialty pharmaceutical focused on pain relief therapies was hit on Monday by a class action lawsuit announcement from law firm Levi & Korsinsky.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
By Jocelyn Aspa
The cleantech sector has emerged as one of the most vital markets today, and investor interest is growing. Here’s a cleantech investing facts rundown for those new to the space.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
From Canadian LPs banding together asking for tougher promotional regulations to the acquisition of ABcann by Cannabis Wheaton and a variety of market news INN provides a roundup of the week in cannabis.
A new bill in the US Senate is looking to decriminalize marijuana at a federal level in the country, potentially ending what in the market has been a gray area as to the legality of cannabis businesses in America.
Sen. Cory Booker introduced the Marijuana Justice Act through Facebook’s (NASDAQ:FB) live
As medical devices get technological advancements placing them into networks, the danger of threats to these crucial devices is growing as well. A new piece of legislation in the US Senate seeks to add mandated tests and better protections for remote access points.
On his first three months as commissioner of the Food and Drug Administration, Scott Gottlieb has already taken significant steps to spark competition in the pharmaceutical space and help bring down the costs of some vital products.
Bion Environmental Technology (OTCQB:BNET), a developer of advanced livestock waste treatment and resource recovery technology, announced it has filed a continuation of its September 2015 patent for a livestock ammonia recovery process that converts the ammonia into stable ammonium bicarbonate. The filing will provide broadened protection for improvements to the technology
The return of John McCain, recently diagnosed with brain cancer, and a tiebreaker 51-50 vote from the Vice President sent the Republican health care plan ahead to begin debate on the Senate floor.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
From Uruguay’s full legalization to the debate between regional leaders in Canada questioning the recreational deadline, and a variety of market news INN provides a roundup of the week in cannabis
